SL immunotherapy is contraindicated in severe asthma. In addition, no data are available for simultaneous treatment of multiple sensitivity. It is recommended that subcutaneous immunotherapy not be given to patients with uncontrolled asthma.
Allergen immunotherapy has been used in medical practice to successfully treat hypersensitivity to many allergens, including dust mites, grass, ragweed, tree pollen, insect venom, and animal dander. Allergen immunotherapy is appropriate for patients suffering from immunoglobulin E–mediated allergic diseases, such as seasonal allergic rhinitis, perennial rhinitis, allergic asthma, and insect venom anaphylaxis.
Effective treatment reduces symptoms and medication use while improving quality of life. Allergen immunotherapy has demonstrated long-term effectiveness in symptom reduction more than 3 years after treatment cessation and has prevented the development of new sensitizations in children. Allergen immunotherapy results in a long-term reduction in serum allergen-specific immunoglobulin E levels. Significant reductions in the early-phase response have also been demonstrated.
For more on immunotherapy for allergies, read here.
Medscape © 2020 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Michael A. Kaliner. Fast Five Quiz: Test Your Knowledge About Fall Allergies - Medscape - Jul 06, 2020.